The Novo Nordisk-Hims & Hers Feud Is Over

Novo Nordisk just swapped a courtroom fight for a sales deal with Hims & Hers—and investors loved it, reports CNBC . The Danish drugmaker has dropped its patent-infringement case against the telehealth company after Hims agreed to sell Novo's branded weight-loss drugs Ozempic and Wegovy through its platform, at prices...